TAIPEI, Taiwan – With Singapore-headquartered Aslan Pharmaceuticals Pte. Ltd. last week announcing that it had opened a new office here, the company has moved that much closer toward its goal of taking advantage of clinical trial infrastructure in Asia to develop novel medicines for global markets.